Cargando…
A research agenda for moving early medical pregnancy termination over the counter
Given the overall safety profile and increasing availability of medical pregnancy termination drugs, we asked: would the mifepristone–misoprostol regimen for medical termination at ≤10 weeks of gestation meet US Food and Drug Administration regulatory criteria for over‐the‐counter (OTC) approval, an...
Autores principales: | Kapp, N, Grossman, D, Jackson, E, Castleman, L, Brahmi, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637897/ https://www.ncbi.nlm.nih.gov/pubmed/28317327 http://dx.doi.org/10.1111/1471-0528.14646 |
Ejemplares similares
-
Pain management for medical and surgical termination of pregnancy between 13 and 24 weeks of gestation: a systematic review
por: Jackson, E, et al.
Publicado: (2020) -
Recurrent Methemoglobinemia From Over-the-Counter Medication
por: Mada, Pradeep Kumar, et al.
Publicado: (2023) -
The use, perceptions and knowledge of safety of over-the-counter medications during pregnancy in a Canadian population
por: Casey, E, et al.
Publicado: (2023) -
A health systems resilience research agenda: moving from concept to practice
por: Saulnier, Dell D, et al.
Publicado: (2021) -
Over-the-counter Medication Sales Surveillance for Early Detection of Respiratory Epidemics in Rural China
por: Qin, Qin, et al.
Publicado: (2014)